Sonoma Pharmaceuticals (SNOA) EBT Margin Growth (1y) (2011 - 2026)
Sonoma Pharmaceuticals (SNOA) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -1,585.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -27.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -356.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 436.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -629.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 208.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn | 2,578.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,578.00 |
| Mar 31, 2026 | 513.00 |
| Dec 31, 2025 | 396.00 |
| Sep 30, 2025 | -11.00 |
| Jun 30, 2025 | -153.00 |
| Mar 31, 2025 | 2,545.00 |
| Dec 31, 2024 | 363.00 |
| Sep 30, 2024 | 3,459.00 |
| Jun 30, 2024 | 1,294.00 |
| Mar 31, 2024 | 823.00 |
| Dec 31, 2023 | 3,529.00 |
| Sep 30, 2023 | -2,000.00 |
| Jun 30, 2023 | -1,919.00 |
| Mar 31, 2023 | 9,508.00 |
| Dec 31, 2022 | -3,218.00 |
| Sep 30, 2022 | -2,499.00 |
| Jun 30, 2022 | 666.00 |
| Mar 31, 2022 | -1,245.00 |
| Dec 31, 2021 | -2,389.00 |
| Sep 30, 2021 | 679.00 |